Sources Sought Electronic Prescribing of Controlled Substances
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of State, Bureau of Medical Services (MED), through its ACQUISITIONS - AQM MOMENTUM office, has issued a Sources Sought / Request for Information (RFI) for Electronic Prescribing (eRx) and Electronic Prescribing of Controlled Substances (EPCS) solutions. This RFI aims to gather information to enhance patient safety, streamline provider workflows, and ensure regulatory compliance. Responses are due by April 10, 2026.
Scope of Work
The Department is seeking solutions with comprehensive capabilities, including:
- eRx Functionality: Creation, modification, renewal, and transmission of prescriptions to U.S. pharmacies; support for medication history, drug-allergy/interaction checks, formulary access, and refill management.
- EPCS Compliance: Adherence to federal and state regulations (including DEA), two-factor authentication, secure audit trails, integrated Prescription Drug Monitoring Program (PDMP) query, automated checks, and display of recent controlled substance fill history.
- Integration: Capability to integrate with the Department’s existing electronic medical system using industry standards (HL7, FHIR, APIs), support for single sign-on (SSO), and real-time data exchange.
- Security & Compliance: Adherence to HIPAA and HITECH, robust data encryption, and comprehensive audit logs.
- User Experience & Support: Intuitive interface, availability of training and technical support, mobile/remote prescribing, and task dashboards.
- Clinical Safety & Decision Support: Real-time drug interaction checking, duplicate therapy detection, dose range checking, and controlled substance risk alerts.
- Reporting: Prescribing activity dashboards, antimicrobial stewardship, and quality metric reporting.
Contract & Timeline
- Type: Sources Sought / Request for Information (RFI)
- Set-Aside: None
- Response Due: April 10, 2026
- Published: May 4, 2026
Evaluation
This RFI is for information and planning purposes only. Responses will be used to inform future acquisition strategies and do not constitute a solicitation or a promise to issue one.
Additional Notes
Respondents should submit a written response detailing their company overview, proposed solution, integration experience, implementation approach, training/support services, and case studies/references. Questions and responses should be directed to Alicia Hofhine at HofhineAK@state.gov.